- •HSP represents a clinically and genetically heterogeneous group of neurodegenerative disorders.
- •The role of MRI in HSPs.
- •The neuroimaging evaluation of a large cohort of diverse subtypes of HSP with a paediatric onset.
- •MRI patterns may provide relevant clues for HSP diagnosis.
Hereditary spastic paraplegias (HSPs) are a clinically and genetically heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and weakness of the lower limbs with a notable phenotypic variation and an autosomal recessive (AR), autosomal dominant (AD), and X-linked inheritance pattern. The recent clinical use of next generation sequencing methods has facilitated the diagnostic approach to HSPs, but the diagnosis remains quite challenging considering its wide clinical and genetic heterogeneity. In this scenario, magnetic resonance imaging (MRI) emerges as a valuable tool in helping to exclude mimicking disorders and to guide genetic testing. The aim of this study is to investigate the presence of possible patterns of morphostructural MRI findings that may provide relevant clues for a specific genetic HSP subtype. In our cohort, for example, white matter abnormalities were the most common finding followed by the thinning of the corpus callosum, which, interestingly, presented different thinning characteristics depending on the HSP subtype.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the Neurological Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.Neuroepidemiology. 2014; 42: 174-183
- Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study.JAMA Neurol. 2013; 70: 746-755
- Next generation molecular diagnosis of hereditary spastic paraplegias: an Italian cross-sectional study.Front. Neurol. 2018; 9: 1-13
- Hereditary ataxias and paraparesias: clinical and genetic update.Curr. Opin. Neurol. 2018; 31: 462-471
- Clinical application of next generation sequencing in hereditary spinocerebellar ataxia: increasing the diagnostic yield and broadening the ataxia-spasticity spectrum. A retrospective analysis.Neurogenetics. 2018; 19: 1-8
- Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches.Lancet Neurol. [Internet]. 2019; 18 (Available from): 1136-1146
- Neuroimaging in hereditary spastic paraplegias: Current use and future perspectives.Front Neurol. 2019; 10: 1-10
- Defining the clinical-genetic and neuroradiological features in SPG54: description of eight additional cases and nine novel DDHD2 variants.J. Neurol. [Internet]. 2019; 266 (Available from): 2657-2664
- Identification of mutations in AP4S1/SPG52 through next generation sequencing in three families.Eur. J. Neurol. 2016; 23: 1580-1587
- Clinical and neuroimaging features of autosomal recessive spastic paraplegia 35 (SPG35): case reports, new mutations, and brief literature review.Neurogenetics. 2018; 19: 123-130
- Classification of the hereditary ataxias and paraplegias.Lancet. 1983; 321: 1151-1155
- The spastic paraplegia rating scale (SPRS): a reliable and valid measure of disease severity.Neurology. 2006; 67: 430-434
- Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7.Neurology. 2019; 92: 2679-2690
- “Ears of the lynx” MRI sign is associated with SPG11 and SPG15 hereditary spastic paraplegia.Am. J. Neuroradiol. 2019; 40: 199-203
- Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability.J. Med. Genet. 2011; 48: 141-144
- Autosomal recessive spastic tetraplegia caused by AP4M1 and AP4B1 gene mutation: expansion of the facial and neuroimaging features.Am. J. Med. Genet. Part A. 2014; 164: 1677-1685
- Autosomal dominant spastic paraplegias: a review of 89 families resulting from a Portuguese survey.JAMA Neurol. 2013; 70: 481-487
- The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes.Neurogenetics. 2018; 19: 111-121
- Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations.J. Neurol. 2015; 262: 1961-1971
- Hereditary spastic paraplegia SPG4: what is known and not known about the disease.Brain. 2015; 138: 2471-2484
- SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage.NeuroImage Clin. [Internet]. 2018; 19 (Available from): 848-857
- Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia.Ann. Neurol. 2007; 62: 656-665
- Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration.Brain. 2008; 131: 772-784
- Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).Ann. Neurol. 2010; 68: 611-618
- Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48.Brain. 2014; 137: 1907-1920
- Novel mutations in FA2H-associated neurodegeneration: an underrecognized condition?.J. Child Neurol. 2013; 28: 1500-1504
- Novel FA2H mutation in a girl with familial spastic paraplegia.J. Neurol. Sci. 2015; 357: 332-334
- Uniparental disomy of chromosome 16 unmasks recessive mutations of FA2H/SPG35 in 4 families.Neurology. 2016 Jul 12; 87 (Epub 2016 Jun 17. PMID: 27316240; PMCID: PMC4940069): 186-191https://doi.org/10.1212/WNL.0000000000002843
- Genetic and phenotypic characterization of complex hereditary spastic paraplegia.Brain. 2016; 139: 1904-1918
- Atypical adult onset complicated spastic paraparesis with thin corpus callosum in two patients carrying a novel FA2H mutation.Eur. J. Neurol. 2012; 19: 1-3
- Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly.Hum. Mol. Genet. 2015; 24: 2218-2227
- Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms.Exp. Neurol. 2014; 261: 518-539
- Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-Person syndrome and other movement disorders.BMC Neurol. 2004; 4: 1-14
- Hereditary spastic paraplegia: novel mutations and expansion of the phenotype variability in SPG56.Eur. J. Paediatr. Neurol. [Internet]. 2016; 20 (Available from): 444-448
- Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.Am. J. Hum. Genet. 2012; 91: 1051-1064
- CYP2U1 activity is altered by missense mutations in hereditary spastic paraplegia 56.Hum. Mutat. 2018; 39: 140-151
- Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis.J. Neurol. 2014; 261: 373-381
- Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia.Neuroradiology. 2005; 47: 730-734
- MR imaging findings in autosomal recessive hereditary spastic paraplegia.Am. J. Neuroradiol. 2009; 30: 936-940
- Hereditary spastic paraplegia: beyond clinical phenotypes toward a unified pattern of central nervous system damage.Radiology. 2015; 276: 207-218
- Clinical and genetic study of hereditary spastic paraplegia in Canada.Neurol. Genet. 2016; 3: 1-8
- Multimodal mri-based study in patients with SPG4 mutations.PLoS One. 2015; 10: 1-11
Published online: April 10, 2021
Accepted: April 5, 2021
Received in revised form: March 6, 2021
Received: December 29, 2020Editor: Nicole Villemarette-Pittman
© 2021 Elsevier B.V. All rights reserved.